Evidence map›Paper›PMID 31863244›Full record

ArticleJournal of clinical immunology2020

Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet).

Federica Pulvirenti, Maria Sangerardi, Alessandro Plebani, Annarosa Soresina, Andrea Finocchi, Claudio Pignata, Emilia Cirillo, Antonino Trizzino, Alessandro Aiuti, Maddalena Migliavacca and 9 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 1 country.

Federica PulvirentiDepartment of Infective diseases and Internal Medicine, Unit of Primary Immunodeficiencies in adults, Policlinico Umberto I, Rome, Italy.
Maria SangerardiPediatric Clinic, Policlinico Giovanni XXIII Hospital, Bari, Italy.
Alessandro PlebaniDepartment of Pediatrics, ASST Spedali Civili of Brescia, Unit of Pediatric Immunology, Brescia, Italy.
Annarosa SoresinaDepartment of Pediatrics, ASST Spedali Civili of Brescia, Unit of Pediatric Immunology, Brescia, Italy.
Andrea FinocchiDepartment of Pediatrics, Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.
Claudio PignataDepartment of Translational Medical Sciences Pediatric Section, Federico II University, Naples, Italy.
Emilia CirilloDepartment of Translational Medical Sciences Pediatric Section, Federico II University, Naples, Italy.
Antonino TrizzinoPediatric Hematology and Oncology Unit, Oncology Department, ARNAS Hospitals Civico, Di Cristina e Benfratelli, Palermo, Italy.
Alessandro AiutiSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Vita-Salute San Raffaele University, Milan, Italy.
Maddalena MigliavaccaSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Vita-Salute San Raffaele University, Milan, Italy.
Franco LocatelliDepartment of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alice BertainaDepartment of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Samuele NaviglioInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Maria CarrabbaDepartment of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marco De CarliSecond Unif of Internal Medicine, University Hospital Santa Maria della Misericordia, Udine, Italy.
Maria Grazia Foschino BarbaroUnit of Psychology, Policlinico Giovanni XXIII Hospital, Bari, Italy.
Marco GattornoUO Pediatria 2, Istituto G. Gaslini, Genoa, Italy.
Isabella QuintiDepartment of Infective diseases and Internal Medicine, Unit of Primary Immunodeficiencies in adults, Policlinico Umberto I, Rome, Italy.
Baldassarre MartireUnit of Pediatric Haemato-Oncology, Policlinico Giovanni XXIII Hospital, University of Bari, Piazza Giulio Cesare, 11, 70124, Bari, Italy. baldo.martire@gmail.com.
Bambino Gesù Children's Hospital · ITOspedale Pediatrico Giovanni XXIII · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITFederico II University Hospital · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIRCCS Materno Infantile Burlo Garofolo · ITIstituto Giannina Gaslini · ITOspedale Santa Maria della Misericordia di Udine · ITPoliclinico Umberto I · ITSapienza University of Rome · ITThe San Raffaele Telethon Institute for Gene Therapy · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections, inflammation, and autoimmunity with an impact on health-related quality of life (HRQoL). Few data are available for children, whereas no study has been conducted in adults. Here, we investigated HRQoL and emotional functioning of 19 children and 28 adults enrolled in Italian registry for CGD. PEDsQL and SDQ were used for children and their caregivers, and adults completed the SF-12 questionnaire. Mean scores were compared with norms and with patients affected by chronic diseases. Comparisons were made for CGD patients who underwent or not hematopoietic stem cell transplantation (HSCT). When compared with norms, CGD children exhibited higher difficulties in social/school areas, peer relationship, and conduct/emotional problems (< 5 years of age), as scored by proxies. Differently, CGD adults reported higher difficulties both in mental and physical area than norms. Only for children, clinical status had a damaging effect on psychosocial and school dimensions, whereas age had a negative impact on social areas. No significant difference was observed between patients treated or not with HSCT. When compared with patients affected by chronic diseases, CGD children and adults both displayed fewer physical disabilities. Differently, in mental scale adults scored lower than those with rheumatology diseases and had similar impairment in comparison with patients with diabetes mellitus and cancer. This study emphasized the impact of CGD on HRQoL since infancy and its decline in adulthood, with emotional difficulties occurring early. HRQoL impairment should be considered in clinical picture of CGD and pro-actively assessed and managed by clinicians.

Indexed as

AdolescentAdultCaregiversChildChild, PreschoolCholestyramine ResinFemaleGranulomatous Disease, ChronicHumansImmunologic Deficiency SyndromesItalyMaleMiddle AgedPsychological DistressQuality of LifeRegistriesCholestyramine Resinburden of diseaseChronic granulomatous diseaseemotional difficultieshealth-related quality of lifehematopoietic stem cell transplantationPEDsQLSDQSF-12

Identifiers

PMID31863244
OpenAlexW2995218993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.